Working… Menu

Disease Burden of Pneumonia, Meningitis and Bacteremia Among Children in Japan: Pneumonet Japan

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00757575
Recruitment Status : Completed
First Posted : September 23, 2008
Last Update Posted : March 27, 2012
Information provided by (Responsible Party):

Brief Summary:
Streptococcus pneumoniae is a major cause of pneumonia, among infants and children in Japan and worldwideThis study plans to investigate the rate of invasive pneumococcal disease "IPD " and the rate of hospitalizations due to pneumonia in Okinawa and the Eastern half of Hokkaido Currently, only a limited information about pneumococcal disease burden is available in Japan.

Condition or disease
Pneumococcal Disease

Layout table for study information
Study Type : Observational
Actual Enrollment : 28511 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Epidemiological Surveillance Network Study To Assess the Disease of Pneumonia in Infants and Children in Japan
Study Start Date : February 2008
Actual Primary Completion Date : October 2010
Actual Study Completion Date : October 2010

Resource links provided by the National Library of Medicine


Primary Outcome Measures :
  1. 1.Describe the distribution of causal pathogen of meningitis and bacteremia 2.Estimate the hospital admission rate of pneumonia patients 3.Estimate the incidence rate of IPD 4.Describe the serotype distribution of S. pneumoniae [ Time Frame: 2 years ]

Secondary Outcome Measures :
  1. 1.CFRof patients admitted with IPD and/or pneumonia. 2.Antibiotic resistance rate of S. pneumoniae 3.Risk factor distribution 4.Average duration of the hospitalization of patients with IPD, meningitis, and/or pneumonia. [ Time Frame: 2-3 years ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   up to 60 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Infants and children less than 5 years of age living in Okinawa and Eastern Hokkaido.

Eligibility Criteria

- Children residing in the surveillance area(s) aged 28 days to <60 months with clinical suspicion of pneumonia, meningitis and bacteremia who were admitted to the hospital.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00757575

Layout table for location information
Kushiro, Hokkaido, Japan, 085-0032
Naha City, Okinawa, Japan, 900-0034
Sponsors and Collaborators
Layout table for investigator information
Study Director: Pfizer Call Center Wyeth is now a wholly owned subsidiary of Pfizer
Layout table for additonal information
Responsible Party: Pfizer Identifier: NCT00757575    
Other Study ID Numbers: 0887X1-4424
First Posted: September 23, 2008    Key Record Dates
Last Update Posted: March 27, 2012
Last Verified: March 2012
Keywords provided by Pfizer:
Additional relevant MeSH terms:
Layout table for MeSH terms
Pneumococcal Infections
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Streptococcal Infections
Gram-Positive Bacterial Infections
Bacterial Infections